# Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents

> **NCT06575738** · PHASE1 · RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 40 (estimated)

## Conditions studied

- Obesity
- Adolescent Obesity
- Body-Weight Trajectory
- Weight Loss Trajectory
- Bariatric Surgery
- Anti-obesity Agents

## Interventions

- **DRUG:** Injectable semaglutide
- **BEHAVIORAL:** Standard postoperative care

## Key facts

- **NCT ID:** NCT06575738
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-11
- **Primary completion:** 2027-09-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06575738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06575738, "Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06575738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*